We are live on !
Find out more
Boxer Capital Portfolio holdings
AUM
$2.04B
Turnover
20.83%
1-Year Est. Return
108.39%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+108.39%
3 Year Est. Return
+261.8%
5 Year Est. Return
+1,135.1%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$10.6M
(+10%)
Cap. Flow
+$24.6M
Cap. Flow % of AUM
Cap. Flow %
21.81%
Top 10 Holdings %
Top 10 Hldgs %
74.15%
Holding
28
New
6
Increased
4
Reduced
2
Closed
5
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Healthcare
ACHC
|
+$11.8M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$7.7M |
| 3 |
CLVS
Clovis Oncology
CLVS
|
+$6.58M |
| 4 |
TSRO
Tesaro
TSRO
|
+$3.34M |
| 5 |
BeOne Medicines
ONC
|
+$2.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPXX
Celator Pharmaceuticals
CPXX
|
+$9.22M |
| 2 |
VTAE
Vitae Pharmaceuticals
VTAE
|
+$2.09M |
| 3 |
ZGNX
Zogenix
ZGNX
|
+$1.55M |
| 4 |
SPHS
Sophiris Bio
SPHS
|
+$786K |
| 5 |
Achieve Life Sciences
QUIT
|
+$60K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
Boxer Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Boxer Capital held 28 positions worth $113M, up 10% from $102M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Boxer Capital deployed $24.6M of net new capital in Q2 2016, opening 6 new positions and adding to 4 existing holdings. Its largest new stake was Acadia Healthcare: 200,938 shares worth $6.52M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 89% a quarter earlier.
On the sell side, the largest reduction was Seagen, an estimated $38K trimmed.
- Boxer Capital's largest Q2 2016 buy was Acadia Healthcare: 200,938 shares worth $6.52M.
- Boxer Capital added most to BeOne Medicines in Q2 2016, an estimated $2.25M increase.
- Boxer Capital's biggest Q2 2016 reduction was Seagen, cutting an estimated $38K.
- Boxer Capital fully exited Celator Pharmaceuticals in Q2 2016, selling an estimated $9.22M.
- Boxer Capital's ten largest holdings make up 74% of its $113M portfolio in Q2 2016.
- Boxer Capital opened 6 new positions and closed 5 in Q2 2016.
- Boxer Capital's portfolio value rose 10% quarter-over-quarter to $113M.
Based on Boxer Capital's 13F filing for Q2 2016, filed 15 Aug 2016.